Current
27.1×
5-Year Average
21.3×
All-Time High
288.6×
All-Time Low
9.1×
P/E Ratio daily chart for Johnson & Johnson (JNJ)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/E Ratio for Johnson & Johnson (JNJ) from 2001 to 2025
| 2025 | $504.08B | $26.80B | 18.8× | -5.7× | |
| 2024 | $345.01B | $14.07B | 24.5× | +13.8× | |
| 2023 | $377.30B | $35.15B | 10.7× | -15.0× | |
| 2022 | $461.69B | $17.94B | 25.7× | +4.2× | |
| 2021 | $449.74B | $20.88B | 21.5× | -6.6× | |
| 2020 | $414.30B | $14.71B | 28.2× | +2.8× | |
| 2019 | $384.00B | $15.12B | 25.4× | +2.4× | |
| 2018 | $351.53B | $15.30B | 23.0× | -265.6× | |
| 2017 | $375.13B | $1.30B | 288.6× | +269.7× | |
| 2016 | $311.82B | $16.54B | 18.9× | +0.5× | |
| 2015 | $283.01B | $15.41B | 18.4× | +0.5× | |
| 2014 | $291.04B | $16.32B | 17.8× | -0.8× | |
| 2013 | $258.34B | $13.83B | 18.7× | +0.7× | |
| 2012 | $194.77B | $10.85B | 17.9× | -0.6× | |
| 2011 | $178.94B | $9.67B | 18.5× | +5.8× | |
| 2010 | $169.65B | $13.33B | 12.7× | -1.8× | |
| 2009 | $177.64B | $12.27B | 14.5× | +1.7× | |
| 2008 | $165.99B | $12.95B | 12.8× | -5.2× | |
| 2007 | $190.47B | $10.58B | 18.0× | +0.6× | |
| 2006 | $192.28B | $11.05B | 17.4× | -0.3× | |
| 2005 | $179.39B | $10.15B | 17.7× | -4.4× | |
| 2004 | $188.24B | $8.51B | 22.1× | +0.8× | |
| 2003 | $153.33B | $7.20B | 21.3× | -2.9× | |
| 2002 | $159.73B | $6.60B | 24.2× | -7.4× | |
| 2001 | $179.37B | $5.67B | 31.6× | — |
- 202518.8×
- 202424.5×
- 202310.7×
- 202225.7×
- 202121.5×
- 202028.2×
- 201925.4×
- 201823.0×
- 2017288.6×
- 201618.9×
- 201518.4×
- 201417.8×
- 201318.7×
- 201217.9×
- 201118.5×
- 201012.7×
- 200914.5×
- 200812.8×
- 200718.0×
- 200617.4×
- 200517.7×
- 200422.1×
- 200321.3×
- 200224.2×
- 200131.6×
About P/E Ratio at Johnson & Johnson (JNJ)
Johnson & Johnson (JNJ) P/E ratio is 27.1× as of June 5, 2026. The 5-year average is 21.3×. The sector median currently stands at 25.0×. The current ratio is at the 83th percentile of its own 10-year history.
Johnson & Johnson (JNJ) historical P/E ratio has ranged from a low of 9.1× (2024) to a high of 288.6× (2017) in the available daily series.
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
Johnson & Johnson P/E Ratio by Year
Johnson & Johnson P/E Ratio 2025: 18.8×
Johnson & Johnson (JNJ) P/E ratio in 2025 was 18.8×, contracted from 24.5× the prior year.
Johnson & Johnson P/E Ratio 2024: 24.5×
Johnson & Johnson (JNJ) P/E ratio in 2024 was 24.5×, expanded from 10.7× the prior year.
Johnson & Johnson P/E Ratio 2023: 10.7×
Johnson & Johnson (JNJ) P/E ratio in 2023 was 10.7×, contracted from 25.7× the prior year.
Johnson & Johnson P/E Ratio 2022: 25.7×
Johnson & Johnson (JNJ) P/E ratio in 2022 was 25.7×, expanded from 21.5× the prior year.
Johnson & Johnson P/E Ratio 2021: 21.5×
Johnson & Johnson (JNJ) P/E ratio in 2021 was 21.5×.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Healthcare peers of Johnson & Johnson (JNJ), ranked by P/E ratio.
| 22.2× | |
| 22.2× | |
| 21.7× | |
| 21.6× | |
| 21.6× | |
| 21.1× | |
| 21.1× | |
| 21.0× | |
| 20.9× | |
| 20.7× | |
| 20.4× | |
| 19.7× | |
| 18.9× | |
| 18.8× | |
| 18.5× | |
| 18.2× | |
| 17.0× | |
| 15.8× | |
| 13.3× | |
| 13.1× | |
| 12.3× | |
| 11.1× | |
| 8.6× | |
| 7.9× | |
| 7.2× |
- 22.2×
- 22.2×
- 21.7×
- 21.6×
- 21.6×
- 21.1×
- 21.0×
- 20.9×
- 20.7×
- 19.7×
- 18.9×
- 18.5×
- 15.8×
- 13.3×
- 13.1×
- 11.1×
- 7.9×
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric